Inspire Medical Systems Inc (INSP)

Cash conversion cycle

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Days of inventory on hand (DOH) days 44.36 39.07 35.56 30.70 22.42 17.75 15.25 12.84 11.16 15.32 25.69 30.09 26.55 24.88 24.47 25.27 21.15 26.66 45.03 53.17
Days of sales outstanding (DSO) days 42.31 43.35 41.23 39.95 52.51 45.74 44.11 46.89 55.02 51.14 49.33 48.44 53.94 48.82 52.39 59.49 80.39 81.33 46.55 46.49
Number of days of payables days 21.42 20.24 20.25 27.46 25.70 27.22 29.23 29.90 25.21 20.53 18.85 23.07 17.97 15.96 15.98 20.10 17.99 20.05 23.06 42.72
Cash conversion cycle days 65.25 62.19 56.53 43.19 49.23 36.28 30.12 29.83 40.97 45.92 56.18 55.46 62.52 57.75 60.88 64.66 83.56 87.94 68.53 56.94

December 31, 2024 calculation

Cash conversion cycle = DOH + DSO – Number of days of payables
= 44.36 + 42.31 – 21.42
= 65.25

The cash conversion cycle of Inspire Medical Systems Inc has shown fluctuations over the past few years.

The cash conversion cycle measures the time it takes for a company to convert its investments in inventory and other resources into cash flows from sales. A shorter cash conversion cycle generally indicates that a company efficiently manages its working capital.

From March 2020 to December 2020, the cash conversion cycle increased from 56.94 days to 83.56 days, indicating a slower conversion of inventory into cash during this period. However, the cycle improved in the following quarters, reaching a low of 29.83 days by March 2023, suggesting increased efficiency in managing working capital and generating cash flows.

Subsequently, the cash conversion cycle slightly increased and fluctuated between 30.12 days and 65.25 days from June 2023 to December 2024. Overall, the company seems to have maintained a relatively efficient cash conversion cycle during this period.

It is essential for Inspire Medical Systems Inc to continue monitoring and managing its cash conversion cycle effectively to ensure optimal working capital management and sustainable cash flow generation.